Prognostic significance of blood coagulation tests in lung cancer

Ferrigno D., Buccheri G., Ricca I.

Source: Eur Respir J 2001; 17: 667-673
Journal Issue: April

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ferrigno D., Buccheri G., Ricca I.. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J 2001; 17: 667-673

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic significance of blood coagulation tests in lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 231s
Year: 2001

Is there any diagnostical significance of blood analyses in patients with lung cancer?
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Prognostic significance of plasma D-dimer (DD) in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002

Absolute neutrophil count in peripheral blood predict prognosis in lung cancer patients treated with anlotinib
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021

Study on coagulation abnormality and effect of anticoagulation on prognosis in advanced cases of non-small cell lung cancer
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Prognostic parameters in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011


Correlation between the activation of coagulation-fibrinolysis system and prognosis of nonsmall cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 231s
Year: 2001

The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011


Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology
Source: Eur Respir J 2013; 41: 410-416
Year: 2013



RARβ2 methylation level in blood for lung cancer assessment
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer
Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017
Year: 2018



Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Prognostic factors in patients with lung cancer and brain metastases at presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007

Free plasmatic circulating DNA as prognostic and diagnostic lung cancer biomarker
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019